Blog
INTU's FedNow Integration: Will It Strengthen Its Competitive Edge?
Intuit INTU recently announced that it has joined the Federal Reserve’s instant payments network, FedNow Service, through the completion of its certification and readiness program. This integration
Is AMD Stock's 31.42X P/E Still Worth it? Buy, Sell or Hold?
Advanced Micro Devices AMD shares are overvalued, as suggested by a Value Score of F. The AMD stock is trading at a forward 12-month price/earnings (P/E) of 31.42X compared with the broader Zacks
Simulations Plus Q2 Earnings & Revenues Beat, Jump Y/Y, Shares Soar
Simulations Plus, Inc. SLP reported second-quarter fiscal 2026 adjusted earnings of 35 cents per share, surpassing the Zacks Consensus Estimate by 29%. The bottom line also compared favorably with
MercadoLibre Balances Scale and Profitability: Hold or Fold the Stock?
MercadoLibre MELI remains a key player in Latin America's digital commerce and fintech landscape, supported by continued expansion across logistics, payments and credit. MELI has been scaling its
Best Momentum Stocks to Buy for April 10th
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, April 10:
Guardian Pharmacy Services, Inc. GRDN: This pharmacy service company has a Zacks
Can Quanta's $44B Backlog Sustain Double-Digit Growth Through 2030?
Quanta Services, Inc. PWR has entered a new phase of long-term visibility, underpinned by a record backlog of approximately $44 billion. Management emphasized that this backlog is broad-based across
Rubrik Bets Big on AI Security: Is Agent Cloud a Growth Driver?
Rubrik’s RBRK aggressive push into AI security through Agent Cloud is emerging as a credible new growth driver. The company’s newly launched Rubrik Agent Cloud (RAC) extends its core platform into
BlackBerry's Shares Rally 8% on Q4 Earnings Beat, Revenues Surge Y/Y
BlackBerry Limited BB reported fourth-quarter fiscal 2026 non-GAAP earnings per share (EPS) of 6 cents. The figure beat the company’s estimate of 3-5 cents. In the year-ago quarter, it reported a
Eni Encounters Major Gas and Condensate Reserves in Temsah Concession
Eni S.p.A. E, an Italian integrated energy company, announced a new gas and condensate discovery in Egypt at the Denise W 1 exploration well. The exploration well was drilled in the Temsah
Is Capacity Expansion Driving DPRO's Shift Into a Defense Manufacturer?
Draganfly’s DPRO current strategy reflects a deliberate shift from a specialized, low-volume drone innovator to a scalable, industrial-grade manufacturer capable of serving both defense and
Chevron Confirms Major Oil Discovery in the Gulf of America
Chevron Corporation CVX has confirmed a promising oil discovery at the Bandit prospect in the Gulf of America, marking a significant development in U.S. offshore exploration. The Bandit prospect
Is This the Right Time to Add Globus Medical Stock to Your Portfolio?
Globus Medical, Inc. GMED is gaining market share in the global musculoskeletal solutions market on the back of the NuVasive merger. The company’s rapid cadence of new product introductions
Thermo Fisher Stock May Benefit Following Collaboration With PRECISE
Thermo Fisher Scientific Inc. TMO has recently teamed up with Precision Health Research, Singapore (“PRECISE”) to advance the PRECISE-SG100K study. The study is supported by Seer, Inc., as a
Biotech ETF (BBC) Touches Fresh 52-Week High
For investors seeking momentum, Virtus Biotech Clinical Trials ETF BBC is probably on the radar now. The fund just hit a 52-week high and jumped 213.9% from its 52-week low price of $14.16 per
Defense ETFs in Spotlight Amid Fading Truce Hopes in the Middle East
The fragile hope for a long-term peace in the Middle East is rapidly thinning. Despite a recently mediated two-week ceasefire between the United States and Iran, hostilities have refused to quieten
ISRG Stock Down Nearly 20% YTD: Should You Buy, Hold or Sell?
Intuitive Surgical ISRG has faced notable pressure in recent months, with its shares losing 19.8% year to date, underperforming the broader medical instruments industry’s decline of 12.1%. Despite
ETFs to Watch as China's Factory Deflation Comes to an End After 3 Years
For the first time in over three years, China’s factory-gate prices have turned positive, marking a historic economic shift. According to recently published data, China’s Producer Price Index (PPI)
Truist Financial Corporation (TFC) Earnings Expected to Grow: Should You Buy?
Truist Financial Corporation (TFC) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known
Fifth Third Bancorp (FITB) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Fifth Third Bancorp (FITB) reports results for the quarter ended March 2026. While this widely-known consensus
Chemung Financial (CHMG) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Chemung Financial (CHMG) reports results for the quarter ended March 2026. While this widely-known consensus
State Street Corporation (STT) Earnings Expected to Grow: Should You Buy?
The market expects State Street Corporation (STT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known
Earnings Preview: Badger Meter (BMI) Q1 Earnings Expected to Decline
The market expects Badger Meter (BMI) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Regions Financial (RF) Earnings Expected to Grow: Should You Buy?
The market expects Regions Financial (RF) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus
Is ADMA Poised for Margin Growth and Supply Expansion in 2026?
ADMA Biologics ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases.
Gross margin improved to 57.4% in 2025 from 51.5% in


